The efficacy of granisetron for cancer patients undergoing platinum-based chemotherapy: comparison of 1 miligram versus 3 miligram doses in preventing nausea and vomiting.

Author: HisyamBarmawi, HutajuluSusanna H, KurniandaJohan, WahyuningsihEndang

Paper Details 
Original Abstract of the Article :
AIM: To compare the efficacy of anti-emetic and prophylactic effects of 1 milligram (mg) versus 3 mg granisetron in cancer patients. METHODS: In this double blind, randomized, parallel study, 2-dose regimens of intra venous (IV) granisetron were evaluated in 39 cancer patients who were treated with...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/16317218

データ提供:米国国立医学図書館(NLM)

Granisetron for Cancer Patients: A Camel's Perspective on Nausea and Vomiting

The field of [oncology] is always seeking to improve the quality of life for [cancer patients] undergoing [chemotherapy]. This research compares the efficacy of different doses of [granisetron] in preventing [nausea and vomiting] associated with [platinum-based chemotherapy]. The authors conducted a [double-blind, randomized, parallel study] involving [39 cancer patients] and found that a [3 mg dose] of [granisetron] was more effective than a [1 mg dose] in preventing [nausea and vomiting]. This study highlights the importance of optimizing medication regimens to manage [chemotherapy] side effects and improve patient comfort.

Finding Relief from Chemotherapy Side Effects: A Camel's Guide to Nausea Control

This study provides valuable insights into the management of [nausea and vomiting] associated with [chemotherapy]. The authors demonstrate that a higher dose of [granisetron] is more effective in preventing [nausea and vomiting] compared to a lower dose. This study encourages healthcare providers to consider optimizing [granisetron] dosages to minimize [nausea and vomiting] and enhance the overall experience for [cancer patients] undergoing chemotherapy.

Camel's Thoughts on Chemotherapy Side Effects

Just as a camel needs to be prepared for the challenges of a long desert journey, individuals undergoing [chemotherapy] need to be aware of potential side effects. This study explores the effectiveness of [granisetron] in mitigating one of the most common side effects of [chemotherapy], [nausea and vomiting], offering a potential way to improve the patient experience during this difficult treatment.

Dr. Camel's Conclusion

This research provides valuable insights into the management of [nausea and vomiting] associated with [platinum-based chemotherapy] in [cancer patients]. The study suggests that a higher dose of [granisetron] may be more effective in preventing these side effects. It's a reminder that, just as a camel can find a respite from the heat in the shade of a tree, individuals undergoing chemotherapy can find relief from [nausea and vomiting] through careful medication management and supportive care.

Date :
  1. Date Completed 2006-02-24
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16317218

DOI: Digital Object Identifier

040579197

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.